Acne vulgaris associated with antigonadotropic (Danazol) therapy.

Cutis · 1979 · vol. 24(4) , pp. 431–3 · PMID:159808 · W2416605694
article OA: closed CC0
View on OpenAlex View on PubMed
AI-generated summary by gemini-2.5-flash-lite, 2026-06-10

A case report details nodulocystic acne development in a woman treated with danazol for endometriosis, highlighting the drug's frequent, yet often unappreciated, androgenic side effects.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

A case of a young woman in whom nodulocystic acne developed while being treated for endometriosis with danazol, an antigonadotropic drug, is described herein. Although this agent, a derivative of 17 alpha-ethinyl testosterone, has been noted to possess weak androgenic properties, it has not been widely appreciated that danazol's androgenic side effects, particularly acne and seborrhea, occur frequently and may require prompt treatment.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Acne Vulgaris Danazol Pregnadienes Acne Vulgaris Adult Danazol Endometriosis Endometriosis Female Humans Pregnadienes

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-09-18T06:10:57.818014+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-14T05:58:48.767648+00:00
License: CC0 · commercial use OK